Benefit of Anti-hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function

被引：0
|
作者：
Lee, Jae Geun [1 ]
Kim, Deok Gie [1 ]
Lee, Jung Jun [2 ]
Kim, Sung Hoon [3 ]
Song, Seung Hwan [4 ]
Lee, Jee Youn [1 ]
Kim, Myoung Soo [1 ]
Ju, Man Ki [1 ]
Choi, Gi Hong [1 ]
Choi, Jin Sub [1 ]
Kim, Soon Il [1 ]
Joo, Dong Jin [1 ]
机构：
[1] Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea
[2] CHA Bundang Med Ctr, Dept Surg, Seoul, South Korea
[3] Yonsei Univ, Dept Surg, Wonju Coll Med, Wonju, South Korea
[4] Ewha Womans Univ, Dept Surg, Coll Med, Seoul, South Korea
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
D O I：
10.1097/01.tp.0000542742.66921.33
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
400.8
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [31] A Controlled Study of the Long-Term Impact on Renal Function of Entecavir and Tenofovir Treatment for Chronic Hepatitis B
    Coelho, Rosa
    Cardoso, Helder
    Vilas-Boas, Filipe
    Rodrigues, Susana
    Gaspar, Rui
    Horta-Vale, Am
    Macedo, Guilherme
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S875 - S875
  • [32] Conversion To Entecavir Monotherapy from Combination Therapy With Hepatitis B Immunoglobulin for Hepatitis B Prophylaxis in Long Term Survivor after Liver Transplantation: Prospective Single Center Trial
    Yi, Nam-Joon
    Lee, Jeong-Moo
    Choi, Youngrok
    Suh, Suk-Won
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    LIVER TRANSPLANTATION, 2014, 20 : S135 - S135
  • [33] Entecavir Combined With Short-term Hepatitis B Immunoglobulin in Preventing Hepatitis B Virus Recurrence in Liver Transplant Recipients
    Zheng, Hao
    Zhu, Zebin
    Wang, Ning
    Qin, Jiwei
    Guo, Yafei
    Xu, Zhijun
    Li, Xuefeng
    Qi, Can
    Yuan, Xiaodong
    Wu, Wei
    Wang, Jizhou
    Liu, Lianxin
    Nashan, Bjorn
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (02) : 408 - 412
  • [34] Early Switching to Subcutaneous Anti-Hepatitis B Virus Immunoglobulins (HBIg) after Liver Transplantation: 12-Month Results of a Single-Center Study
    De Simone, P.
    Carrai, P.
    Leonardi, G.
    Ducci, J.
    Coletti, L.
    Balzano, E.
    Filipponi, F.
    TRANSPLANTATION, 2012, 94 (10) : 431 - 431
  • [35] Long-term outcomes of entecavir monotherapy in patients with treatment-naive chronic hepatitis B
    Kim, Hyung Joon
    Lee, Hyun Woong
    Park, Ji Hoon
    Lee, Kyeong Heon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 248 - 249
  • [36] Residual viral B particles at 10 years post transplantation in patients receiving long term anti-HBs immunoglobulins (HBIG)
    Gigou, M
    Féray, C
    Roche, B
    Afonso, AM
    Shouval, D
    Bismuth, H
    Samuel, D
    JOURNAL OF HEPATOLOGY, 2000, 32 : 31 - 31
  • [37] Long-term outcomes of preventing HBV recurrence with nucleotide and HBIG after liver transplantation for hepatitis B associated liver disease
    Chang, S. H.
    TRANSPLANTATION, 2021, 105 (08) : 93 - 93
  • [38] Long-term outcome of patients undergoing OLT for hepatitis B-related liver disease without HBIG prophylaxis.
    Rinella, ME
    Dasgupta, K
    Schiano, TD
    Lissoos, TW
    Millis, JM
    Baker, AL
    Conjeevaram, HS
    GASTROENTEROLOGY, 1998, 114 (04) : A1328 - A1328
  • [39] Long term prevention of recurrent hepatitis B after liver transplantation using nucleos(t)ide analogs after HBIg discontinuation
    Vu, J.
    Osorio, R. W.
    Cooper, S. L.
    Merriman, R. B.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S184 - S184
  • [40] A PHARMACIST DELIVERED STRATIFIED CONVERSION PROTOCOL FROM HEPATITIS B IMMUNOGLOBULIN (HBIG) TO TENOFOVIR OR ENTECAVIR IS EFFICACIOUS, SAFE AND COST-EFFECTIVE FOR PREVENTION OF RECURRENCE OF HEPATITIS B VIRUS (HBV) IN LIVER TRANSPLANT (LT) RECIPIENTS
    Knighton, Sarah
    Agarwal, Kosh
    Heneghan, Michael A.
    O'Grady, John G.
    Bruce, Matthew J.
    Carey, Ivana
    Heaton, Nigel
    Suddle, Abid
    HEPATOLOGY, 2011, 54 : 619A - 620A
12345